Physician profile
Jillian M Johnston
NPI 1730313297
$2,154.55
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $616 · 2021: $585 · 2022: $371.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.21 | 2019-2022 | |
| Avion Pharmaceuticals | $254.42 | 2019-2021 | |
| Daiichi Sankyo INC. | $205.66 | 2019-2022 | |
| Pfizer INC. | $182.37 | 2019-2021 | |
| Novo Nordisk INC | $169.04 | 2019-2022 | |
| Roche Diagnostics Corporation | $77.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.50 | 2019-2021 | |
| Therapeuticsmd, INC. | $68.80 | 2019-2020 | |
| Exeltis, USA INC. | $66.49 | 2020-2022 | |
| Agile Therapeutics, INC. | $61.24 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $60.74 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.23 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $48.47 | 2019-2020 | |
| Evofem Biosciences, INC. | $41.65 | 2021 | |
| Merck Sharp & Dohme LLC | $40.55 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $33.80 | 2022 | |
| Eisai INC. | $24.55 | 2019 | |
| Coopersurgical, INC. | $23.20 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $20.13 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.47 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.38 | 2019 | |
| Hologic Sales and Service, LLC | $16.90 | 2020 | |
| Sage Therapeutics, LLC | $16.33 | 2021 | |
| Smith+Nephew, INC. | $15.96 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.88 | 2020 | |
| Ethicon US, LLC | $13.26 | 2020 | |
| Allergan, INC. | $12.48 | 2020 | |
| Currax Pharmaceuticals LLC | $12.47 | 2021 | |
| Organon LLC | $11.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.